Skip to main content

Table 4 Number of death and cumulative death rate by follow-up time

From: Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan

 

0-1 year

1-2 years

2-3 years

3-4 years

4-5 years

5-6 years

Treatment type

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

WBRT

10744 (53.1)

12265 (60.6)

12621 (62.4)

12707 (62.8)

12735 (62.9)

12736 (62.9)

WBRT+ gefitinib

1168 (34.6)

1678 (49.7)

1849 (54.7)

1900 (56.2)

1917 (56.7)

1919 (56.8)

WBRT + GK

30 (19.4)

55 (35.5)

68 (43.9)

69 (44.5)

69 (44.5)

69 (44.5)

WBRT + gefitinib + GK

15 (15.2)

30 (30.3)

43 (43.4)

48 (48.5)

52 (52.5)

52 (52.5)